Real-world treatment (Tx) sequences and time to discontinuation (rwTTD) in the first-line (1L) metastatic castration-resistant prostate cancer (mCRPC) setting.
| Autor: | Nash Smyth, Emily, Whipple, Samuel, Guinter, Mark, Haddad, Nadine, Piao, Wenxian, Cui, Zhanglin Lin, Balar, Arjun Vasant |
|---|---|
| Zdroj: | Journal of Clinical Oncology; 2024 Supplement 4, Vol. 42, p55-55, 235p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|